Atticus Wealth Management LLC Acquires 50 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atticus Wealth Management LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 403 shares of the medical equipment provider’s stock after acquiring an additional 50 shares during the period. Atticus Wealth Management LLC’s holdings in Intuitive Surgical were worth $210,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the business. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the third quarter valued at about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ISRG. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Mizuho lifted their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Truist Financial boosted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $583.83.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,453 shares of company stock valued at $22,059,506 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $584.05 on Monday. The firm’s 50 day simple moving average is $547.16 and its 200-day simple moving average is $504.78. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market capitalization of $208.03 billion, a price-to-earnings ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.